Jackson Consulting Group

Development of a Chatbot to answer oncology related questions

We have been developing a AI methods that are specifically focused on answering questions related to oncology drug development. One challenge for antibody drug conjugates (ADCs) is understanding how we can improved the clinical success rates for ADCs. By understanding why certain ADCs fail in the clinic, perhaps this can help guide the next generation of ADCs, which will hopefully address some of the limitations of the current wave of ADCs. ADCs are complex molecules consisti

Dowdy Jackson

Jul 115 min read

Revolutionizing Oncology Drug Discovery with Artificial Intelligence Integration

Cancer remains one of the most complex and challenging diseases to treat. Developing new oncology drugs is a lengthy, costly, and uncertain process. Yet, artificial intelligence (AI) is reshaping how researchers approach drug discovery, offering new tools to accelerate progress and improve outcomes. This post explores how integrating AI into the oncology drug discovery workflow is transforming the field, highlighting practical examples and key benefits. AI-driven oncology dru

Dowdy Jackson

Jun 304 min read

Can machine learning/artificial intelligence improve the clinical success rates of oncology drugs?

Oncology drug development is a multi-billion dollar industry but has a low success rate. How can AI help improve the clinical success rates of oncology drugs?

Dowdy Jackson

May 5, 202513 min read